Chen CB, Pan JJ, Xu LY (2003) Recombinant adenovirus p53 agent injection combined with radiotherapy in treatment of nasopharyngeal carcinoma: a phase II clinical trial. Zhonghua Yi Xue Za Zhi 83:2033–2035
CAS
PubMed
Google Scholar
Chua ML, Wee JT, Hui EP, Chan AT (2015) Nasopharyngeal carcinoma. Lancet (London, England) 387:1012–1024
Article
Google Scholar
Cuddihy AR, Bristow RG (2004) The p53 protein family and radiation sensitivity: yes or no? Cancer Metastasis Rev 23:237–257
Article
CAS
PubMed
Google Scholar
Golubovskaya VM, Conway-Dorsey K, Edmiston SN, Tse CK, Lark AA, Livasy CA, Moore D, Millikan RC, Cance WG (2009) FAK overexpression and p53 mutations are highly correlated in human breast cancer. Int J Cancer 125:1735–1738
Article
CAS
PubMed
PubMed Central
Google Scholar
Gudkov AV, Komarova EA (2003) The role of p53 in determining sensitivity to radiotherapy. Nat Rev Cancer 3:117–129
Article
CAS
PubMed
Google Scholar
Hirao A, Kong YY, Matsuoka S, Wakeham A, Ruland J, Yoshida H, Liu D, Elledge SJ, Mak TW (2000) DNA damage-induced activation of p53 by the checkpoint kinase Chk2. Science (New York, NY) 287:1824–1827
Article
ADS
CAS
Google Scholar
Hughes J, Alusi G, Wang Y (2012) Gene therapy and nasopharyngeal carcinoma. Rhinology 50:115–121
CAS
PubMed
Google Scholar
Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17:1–12
Article
CAS
PubMed
Google Scholar
Kandioler D, Zwrtek R, Ludwig C, Janschek E, Ploner M, Hofbauer F, Kührer I, Kappel S, Wrba F, Horvath M, Karner J, Renner K, Bergmann M, Karner-Hanusch J, Pötter R, Jakesz R, Teleky B, Herbst F (2002) TP53 genotype but not p53 immunohistochemical result predicts response to preoperative short-term radiotherapy in rectal cancer. Ann Surg 235:493–498
Article
PubMed
PubMed Central
Google Scholar
Lan G, Su J, Si Y, He C, Huang B, Zhang Z (2011) Clinical effect of rAd-p53 combined with radiotherapy and chemotherapy on treatment of advanced nasopharyngeal carcinoma. J Pract Med 27:2341–2344
Google Scholar
Lan G, Si Y, Qin Y, Deng Z, He C, Huang B (2012) Recombinant adenoviral human p53 gene combined with radio- and chemotherapy in treatment of advanced nasopharyngeal carcinoma: a randomized clinical study. J Clin Oncol 30(15 suppl 1):5558
Google Scholar
Li HT (2012) Effect of recombinant human P53 adenovirus injection combined with radiotherapy and chemotherapy in treatment of advanced nasopharyngeal carcinoma. J Med Theor Prac 25:1083–1084
Google Scholar
Lo KW, To KF, Huang DP (2004) Focus on nasopharyngeal carcinoma. Cancer Cell 5:423–428
Article
CAS
PubMed
Google Scholar
Ma JT, Han CB, Zhao JZ, Jing W, Zhou Y, Huang LT, Zou HW (2012) Synergistic cytotoxic effects of recombinant human adenovirus p53 and radiation at various time points in A549 lung adenocarcinoma cells. Oncol Lett 4:529–533
PubMed
PubMed Central
Google Scholar
Mitchell AM, Nicolson SC, Warischalk JK, Samulski RJ (2010) AAV’s anatomy: roadmap for optimizing vectors for translational success. Curr Gene Ther 10:319–340
Article
CAS
PubMed
PubMed Central
Google Scholar
Nicolson SC, Samulski RJ (2014) Recombinant adeno-associated virus utilizes host cell nuclear import machinery to enter the nucleus. J Virol 88:4132–4144
Article
PubMed
PubMed Central
Google Scholar
Olivier M, Eeles R, Hollstein M, Khan MA, Harris CC, Hainaut P (2002) The IARC TP53 database: new online mutation analysis and recommendations to users. Hum Mutat 19:607–614
Article
CAS
PubMed
Google Scholar
Pan JJ, Zhang SW, Chen CB, Xiao SW, Sun Y, Liu CQ, Su X, Li DM, Xu G, Xu B, Lu YY (2009) Effect of recombinant adenovirus-p53 combined with radiotherapy on long-term prognosis of advanced nasopharyngeal carcinoma. J Clin Oncol 27:799–804
Article
PubMed
Google Scholar
Qin Y, Weng J, Lan G, Wei H, Huang B, Sun J, Si Y (2012) Effect of p53 gene therapy on the local immunity and the efficacy of patients with nasopharyngeal carcinoma. J Chin Otorhinolaryngol Head Neck Surg (China) 26:980–983
CAS
Google Scholar
Shiomitsu K, Sajo E, Xia X, Hunley DW, Mauldin GE, Li S, Mauldin GN (2008) Radiosensitivity of canine osteosarcoma cells transfected with wild-type p53 in vitro. Vet Comp Oncol 6:193–200
Article
CAS
PubMed
Google Scholar
Si YF, He CC, Lan GP, Huang B, Zhang Z, Lu JL, Zhou RJ, Jiang H (2009) Recombinant adenovirus p53 agent injection combined with radiotherapy and chemotherapy for intermediate and advanced stage nasopharyngeal carcinoma. Chin J Clin Oncol 36:1031–1039
Google Scholar
Sun GG, Zhang J, Ma XB, Wang YD, Cheng YJ, Hu WN (2015) Overexpression of wild-type p53-induced phosphatase 1 confers poor prognosis of patients with nasopharyngeal carcinoma. Pathol Oncol Res 21:283–291
Article
CAS
PubMed
Google Scholar
Wang JC, Wang F, Kong LL, Wu NM, Zhang KL, Zhang L (2010) Recombinant adenovirus p53 combince with radiotherapy in treat ment of nasopharyngeal carcinoma. Acta Universitatis Medicinalis Anhui 45:235–237
Google Scholar
Wang XH, Wang JG, Zhang J, Hu WN, Zhang RJ (2012) Clinical observations of recombinant adenovirus-p53 combined with radiotherapy on nasopharyngeal squamous carcinoma. Mod J Int Tradit Chin West Med 21:924–925, 934
CAS
Google Scholar
Zhang S, Xiao S, Sun Y, Liu C, Su X, Li D, Xu G, Zhu G, Xu B (2006). Clinical trial of recombinant adenovirus-p53 (Gendicine) combined with radiotherapy in nasopharyngeal carcinoma patients. Mol Therapy 13: 280
Zhang SW, Xiao SW, Sun Y, Liu CQ, Su X, Li DM, Xu G, Xu B (2007) Long-Term outcomes of combination of recombinant adenovirus-p53 (Gendicine) with radiotherapy in nasopharyngeal carcinoma. Hum Gene Ther 18:955–993
Article
Google Scholar
Zhang LZ, Zu MZ, Tang TT, Wang JW, Xin YX, Liu GL, Zheng JZ (2011) A phase II study of recombinant adeno-viral human p53 gene combined with radiotherapy and radio- and chemo-therapy in treatment of patients with advanced nasopharyngeal carcinoma. Hum Gene Ther 22:A125
Article
Google Scholar